Literature DB >> 22828861

Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment.

W Lu1, M J W Greuter, M Schaapveld, K M Vermeulen, T Wiggers, G H de Bock.   

Abstract

BACKGROUND: In the Netherlands, the first 5 years of follow-up after treatment for breast cancer are carried out in hospital with yearly mammography. After this, for patients aged over 60 years who have undergone mastectomy, there is a shift of care to the National Screening Programme (NSP) for mammography every 2 years. After breast-conserving therapy follow-up is perfomed by the general practitioner (GP), with mammography every second year and physical examination annually. The aim of this study was to evaluate the clinical effects and costs of four different strategies for follow-up after breast cancer treatment.
METHODS: An extended and validated simulation model for breast cancer follow-up was used. The current guidelines for follow-up (baseline strategy) and three less intensive follow-up strategies were evaluated. The main outcome measure was the detection rate of small tumours (2 cm or smaller) and associated costs for each strategy.
RESULTS: Shortening the follow-up time in hospital by shifting care to the NSP or GP after 2 years instead of 5 years of hospital follow-up, lowering the age of referral to the NSP or GP from 60 to 50 years, and termination of annual physical examination by the GP after hospital follow-up did not decrease the detection of small tumours. In addition, a substantial decrease in costs was observed with simplified follow-up.
CONCLUSION: Decreasing hospital follow-up time, lowering the age of referral to the NSP or GP, and termination of annual physical examinations would lead to a substantial reduction in costs while maintaining the possibility of detecting small breast cancers.
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22828861     DOI: 10.1002/bjs.8850

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysis.

Authors:  Alison M Pearce; Fay Ryan; Frances J Drummond; Audrey Alforque Thomas; Aileen Timmons; Linda Sharp
Journal:  Support Care Cancer       Date:  2015-08-06       Impact factor: 3.603

2.  The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.

Authors:  R G Koleva-Kolarova; M J W Greuter; M van Kruchten; K M Vermeulen; T Feenstra; E Buskens; A W J M Glaudemans; E F J de Vries; E G E de Vries; G A P Hospers; G H de Bock
Journal:  Br J Cancer       Date:  2015-04-16       Impact factor: 7.640

3.  Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study.

Authors:  Kelly M de Ligt; Annemieke Witteveen; Sabine Siesling; Lotte M G Steuten
Journal:  BMC Cancer       Date:  2018-01-24       Impact factor: 4.430

4.  Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran

Authors:  Nahid Hatam; Niloofar Ahmadloo; Mina Vazirzadeh; Abdossaleh Jafari; Mehrdad Askarian
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

5.  Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation.

Authors:  Shuifang Hu; Xiaoxue Wu; Mengchao Wei; Yunyan Ling; Meiyan Zhu; Yan Wang; Yong Chen; Meng Jin; Zhenwei Peng
Journal:  J Oncol       Date:  2022-03-19       Impact factor: 4.375

6.  Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness.

Authors:  G H de Bock; K M Vermeulen; L Jansen; J C Oosterwijk; S Siesling; M D Dorrius; T Feenstra; N Houssami; M J W Greuter
Journal:  Br J Cancer       Date:  2013-04-11       Impact factor: 7.640

7.  Is Age-targeted full-field digital mammography screening cost-effective in emerging countries? A micro simulation model.

Authors:  Fabiano Hahn Souza; Carísi Anne Polanczyk
Journal:  Springerplus       Date:  2013-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.